A detailed history of Rafferty Asset Management, LLC transactions in Roivant Sciences Ltd. stock. As of the latest transaction made, Rafferty Asset Management, LLC holds 666,469 shares of ROIV stock, worth $7.71 Million. This represents 0.03% of its overall portfolio holdings.

Number of Shares
666,469
Previous 877,709 24.07%
Holding current value
$7.71 Million
Previous $9.28 Million 17.1%
% of portfolio
0.03%
Previous 0.03%

Shares

10 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

SELL
$10.17 - $12.5 $2.15 Million - $2.64 Million
-211,240 Reduced 24.07%
666,469 $7.69 Million
Q2 2024

Aug 13, 2024

SELL
$10.36 - $11.74 $357,254 - $404,842
-34,484 Reduced 3.78%
877,709 $9.28 Million
Q1 2024

May 13, 2024

SELL
$9.87 - $11.8 $601,487 - $719,103
-60,941 Reduced 6.26%
912,193 $9.61 Million
Q4 2023

Feb 13, 2024

BUY
$8.38 - $11.58 $1.64 Million - $2.26 Million
195,136 Added 25.08%
973,134 $10.9 Million
Q3 2023

Nov 13, 2023

SELL
$9.76 - $13.19 $142,818 - $193,009
-14,633 Reduced 1.85%
777,998 $9.09 Million
Q2 2023

Aug 11, 2023

SELL
$7.09 - $10.08 $397,571 - $565,236
-56,075 Reduced 6.61%
792,631 $7.99 Million
Q1 2023

May 11, 2023

BUY
$6.92 - $9.98 $3.34 Million - $4.81 Million
482,095 Added 131.5%
848,706 $6.26 Million
Q4 2022

Feb 13, 2023

BUY
$3.36 - $7.99 $733,417 - $1.74 Million
218,279 Added 147.16%
366,611 $2.93 Million
Q3 2022

Nov 14, 2022

BUY
$0.51 - $4.84 $60,227 - $571,574
118,094 Added 390.55%
148,332 $478,000
Q2 2022

Aug 12, 2022

BUY
$2.81 - $4.84 $84,968 - $146,351
30,238 New
30,238 $123,000

Others Institutions Holding ROIV

About Roivant Sciences Ltd.


  • Ticker ROIV
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 704,382,976
  • Market Cap $8.15B
  • Description
  • Roivant Sciences Ltd., a biopharmaceutical and healthcare technology company that researches and develops medicines. The company develops product candidates for the treatment of various therapeutics, including solid tumors, sickle cell diseases, hypophosphatasia, oncologic malignancies, psoriasis, atopic dermatitis, vitiligo, hyperhidrosis, acne...
More about ROIV
Track This Portfolio

Track Rafferty Asset Management, LLC Portfolio

Follow Rafferty Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rafferty Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Rafferty Asset Management, LLC with notifications on news.